Drug Shortage Report for MINT-TOPIRAMATE
| Report ID | 217687 |
| Drug Identification Number | 02315661 |
| Brand name | MINT-TOPIRAMATE |
| Common or Proper name | Topiramate |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOPIRAMATE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 count bottle |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-18 |
| Estimated end date | 2024-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-01-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-01-29 | French | Compare |
| v1 | 2024-01-29 | English | Compare |
Showing 1 to 2 of 2